HI
ROIV icon

Horizon Investments’s Roivant Sciences ROIV Stock Holding History

Horizon Investments’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.65M Buy
46,510
+40,962
+738% +$1.21M 0.02% 580
2026
Q1 		$154K Sell
5,548
-220
-4% -$5.65K ﹤0.01% 1022
2025
Q4 		$125K Buy
+5,768
New +$114K ﹤0.01% 1032

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Horizon Investments's ROIV Position: Q2 2026 in Review

Horizon Investments increased its Roivant Sciences (ROIV) stake by 738% in Q2 2026, buying an estimated $1.21M and bringing the position to 46,510 shares worth $1.65M. The position accounts for 0.02% of the portfolio, ranked #580.

Horizon Investments first reported a position in ROIV in Q4 2025 and has held it in 3 quarters since. 500 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Horizon Investments held 46,510 shares of Roivant Sciences worth $1.65M as of Q2 2026.
  • Horizon Investments bought 40,962 Roivant Sciences shares in Q2 2026, an estimated $1.21M.
  • Roivant Sciences made up 0.02% of Horizon Investments's portfolio in Q2 2026, its #580 holding.
  • Horizon Investments first reported a position in Roivant Sciences in Q4 2025 and has held it in 3 quarters since.
  • 500 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Horizon Investments's 13F filing for Q2 2026, filed 13 Aug 2026.